Abstract
Hepatitis G virus (HGV) was recently identified as a new member of the Flaviviridae, but its clinical significance is still unclear. Since no immunoassay for the diagnosis of HGV is available, we developed a sensitive reverse transcription-PCR (RT-PCR) assay to facilitate the detection of the viral genome by mass screening in the clinical laboratory. Sequences within the 5'-noncoding region and within the putative NS5a region are independently amplified in the presence of digoxigenin-11-dUTP and are detected by hybridization with biotinylated capture probes binding to a streptavidin-coated matrix. Semiquantitative Enzymun-Test DNA detection via chemiluminescence can be performed either in a microtiter plate format or on fully automated ES 300 machines. We were able to detect at least 8 x 10(2) genome equivalents per ml of serum using both primer pairs. HGV was shown to be present in 43 of 130 (33%) serum samples from intravenous drug abusers with a high risk of parenteral exposure. However, only two of the patients were positive when the NS5a primers only were used, and only one patient was positive when only the 5'-noncoding region primers were used, demonstrating the increased sensitivity of HGV detection with two sets of primers. Among these patients, there was no obvious correlation with other viral infections like hepatitis B virus, hepatitis C virus, or human immunodeficiency virus. Within a blood donor panel, 3 of 92 (3%) samples were found to be HGV positive, suggesting that donated blood may need to be screened for HGV.
Full Text
The Full Text of this article is available as a PDF (376.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aikawa T., Sugai Y., Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med. 1996 Jan 18;334(3):195–196. doi: 10.1056/NEJM199601183340316. [DOI] [PubMed] [Google Scholar]
- Alter H. J. The cloning and clinical implications of HGV and HGBV-C. N Engl J Med. 1996 Jun 6;334(23):1536–1537. doi: 10.1056/NEJM199606063342310. [DOI] [PubMed] [Google Scholar]
- Chambers T. J., Hahn C. S., Galler R., Rice C. M. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol. 1990;44:649–688. doi: 10.1146/annurev.mi.44.100190.003245. [DOI] [PubMed] [Google Scholar]
- Chen D. S. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science. 1993 Oct 15;262(5132):369–370. doi: 10.1126/science.8211155. [DOI] [PubMed] [Google Scholar]
- Feucht H. H., Zollner B., Polywka S., Laufs R. Vertical transmission of hepatitis G. Lancet. 1996 Mar 2;347(9001):615–616. [PubMed] [Google Scholar]
- Leary T. P., Muerhoff A. S., Simons J. N., Pilot-Matias T. J., Erker J. C., Chalmers M. L., Schlauder G. G., Dawson G. J., Desai S. M., Mushahwar I. K. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol. 1996 Jan;48(1):60–67. doi: 10.1002/(SICI)1096-9071(199601)48:1<60::AID-JMV10>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
- Linnen J., Wages J., Jr, Zhang-Keck Z. Y., Fry K. E., Krawczynski K. Z., Alter H., Koonin E., Gallagher M., Alter M., Hadziyannis S. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996 Jan 26;271(5248):505–508. doi: 10.1126/science.271.5248.505. [DOI] [PubMed] [Google Scholar]
- Muerhoff A. S., Leary T. P., Simons J. N., Pilot-Matias T. J., Dawson G. J., Erker J. C., Chalmers M. L., Schlauder G. G., Desai S. M., Mushahwar I. K. Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. J Virol. 1995 Sep;69(9):5621–5630. doi: 10.1128/jvi.69.9.5621-5630.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Polish L. B., Gallagher M., Fields H. A., Hadler S. C. Delta hepatitis: molecular biology and clinical and epidemiological features. Clin Microbiol Rev. 1993 Jul;6(3):211–229. doi: 10.1128/cmr.6.3.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schaluder G. G., Dawson G. J., Simons J. N., Pilot-Matias T. J., Gutierrez R. A., Heynen C. A., Knigge M. F., Kurpiewski G. S., Buijk S. L., Leary T. P. Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol. 1995 May;46(1):81–90. doi: 10.1002/jmv.1890460117. [DOI] [PubMed] [Google Scholar]
- Simons J. N., Leary T. P., Dawson G. J., Pilot-Matias T. J., Muerhoff A. S., Schlauder G. G., Desai S. M., Mushahwar I. K. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med. 1995 Jun;1(6):564–569. doi: 10.1038/nm0695-564. [DOI] [PubMed] [Google Scholar]
- Simons J. N., Pilot-Matias T. J., Leary T. P., Dawson G. J., Desai S. M., Schlauder G. G., Muerhoff A. S., Erker J. C., Buijk S. L., Chalmers M. L. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3401–3405. doi: 10.1073/pnas.92.8.3401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zuckerman A. J. Alphabet of hepatitis viruses. Lancet. 1996 Mar 2;347(9001):558–559. doi: 10.1016/s0140-6736(96)91267-2. [DOI] [PubMed] [Google Scholar]